EDGAR Filing Documents for 0001104659-23-102597

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-23-102597

Filing Date

2023-09-21

Accepted

2023-09-21 08:00:11

Documents

Period of Report

2023-09-21

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tm2326559d1_6k.htm	6-K	21431
2	EXHIBIT 10.1	tm2326559d1_ex10-1.htm	EX-10.1	222841
3	EXHIBIT 10.2	tm2326559d1_ex10-2.htm	EX-10.2	99006
4	EXHIBIT 10.3	tm2326559d1_ex10-3.htm	EX-10.3	92918
5	EXHIBIT 99.1	tm2326559d1_ex99-1.htm	EX-99.1	11832
	Complete submission text file	0001104659-23-102597.txt		449216

Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210

Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 231267764
SIC: 2834 Pharmaceutical Preparations